Associations Between Interleukin-10 Polymorphisms and Susceptibility to Sjögren's Syndrome: A Meta-Analysis.

Abstract

This study sought to investigate the association between interleukin-10 (IL10) polymorphisms and susceptibility to Sjögren's syndrome. A systematic search of the Medline, Embase and Web of Science databases was conducted to identify relevant articles from inception to April 2024. No restrictions were placed on race, ethnicity or geographic area, but only studies published in English were included. A meta-analysis was conducted to evaluate the association among the IL10-1082 G/A (rs1800896), -819 C/T (rs1800871) and -592 C/A (rs1800872) polymorphisms, as well as their haplotypes and the risk of developing Sjögren's syndrome. The included studies involved 998 Sjögren's syndrome patients and 1576 controls. Ten studies were included in the meta-analysis. Meta-analysis of the IL10-1082 G/A polymorphism revealed no significant association with Sjögren's syndrome (odds ratio [OR]=1.115, 95% confidence interval [CI]: 0.888-1.401, p=0.343), with stratification by ethnicity yielding consistent results for Europeans and Latin Americans. Similarly, the IL10-819 C/T polymorphism was not associated with Sjögren's syndrome in any study subjects (OR=0.859, 95% CI: 0.648-1.138, p=0.290). The IL10-592 C allele also exhibited no association with Sjögren's syndrome (OR=1.131, 95% CI: 0.776-1.646, p=0.522). However, the GCC carrier status demonstrated a significant association with Sjögren's syndrome across all study subjects (OR=1.496, 95% CI: 1.200-1.865, p<0.001), particularly in Europeans (OR=1.444, 95% CI: 1.085-1.921, p=0.012) and Latin Americans (OR=1.324, 95% CI: 1.115-2.366, p=0.012). A significant protective effect of the homozygous ATA/ATA haplotype on Sjögren's syndrome was found in Europeans (OR=0.320, 95% CI: 0.121-0.846, p=0.022). This meta-analysis indicates a significant link between carrying the GCC haplotype of the IL10-1082 G/A, -819 C/T and -592 C/A polymorphisms and an increased susceptibility to Sjögren's syndrome. Conversely, the homozygous ATA/ATA haplotype appears to confer protection against the risk of Sjögren's syndrome, particularly in European populations.